INHALED LEVODOPA (Inbrija®)

Clinical Indication

For Intermittent treatment of episodic motor fluctuations (OFF episodes) in adult patients with Parkinson’s disease (PD) treated with a levodopa/dopa-decarboxylase inhibitor

Comments

To be used in patients who otherwise would progress to apomorphine

First prescription to be supplied by specialist

Date of classification

February 2026

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .